Prosecution Insights
Prosecution Insights
Technology areas: Semiconductors, Circuits & Optics • Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Eximo Medical Ltd. currently manages 3 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are distributed across 2 distinct art units, indicating a prosecution strategy that covers different technical areas. The portfolio involves 3 distinct examiners, which shows that the company is navigating different perspectives at the patent office. This variety in examiners suggests that the company must adapt its arguments to suit multiple individual review styles within the medical device sector.
ERIC RASSAVONG is identified as the busiest examiner for this portfolio, currently handling 1 pending office action. This single action represents a portion of the total pending actions for the company. Practitioners should note that the workload is distributed, as no single examiner holds all of the pending matters. Because the pending office actions are spread across the distinct examiners, the company avoids over-reliance on the discretion of a single official. This distribution across 2 distinct art units further ensures that the portfolio is evaluated against diverse technical standards.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| §112 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RASSAVONG, ERIC | 1 | 71.6% | +34.4% |
| HOUGH, JESSANDRA F | 1 | 45.6% | +35.8% |
| PYO, KEVIN K | 1 | 87.0% | +9.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18673430 | DEVICES AND METHODS FOR TESTING ABLATION SYSTEMS | PYO, KEVIN K | 20d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18884248 | SMART ASPIRATION SYSTEM AND LASER ACTIVATION SYSTEM | RASSAVONG, ERIC | — |
| 18675359 | HYBRID CATHETER FOR VASCULAR INTERVENTION | HOUGH, JESSANDRA F | — |
| Art Unit | Apps |
|---|---|
| 3796 | 2 |
| 2878 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18884248 | SMART ASPIRATION SYSTEM AND LASER ACTIVATION SYSTEM | RASSAVONG, ERIC | 3796 | §103Other | Non-Final OA | — | Pending | Sep 13, 2024 |
| 18675359 | HYBRID CATHETER FOR VASCULAR INTERVENTION | HOUGH, JESSANDRA F | 3796 | §112Other | Non-Final OA | — | Pending | May 28, 2024 |
| 18673430 | DEVICES AND METHODS FOR TESTING ABLATION SYSTEMS | PYO, KEVIN K | 2878 | §102§103§112 | Non-Final OA | 20d | Pending | May 24, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial